Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany

Dermatology

Volumn 193, Issue 3, 1996, Pages 239-244

  Van Doorslaer, E K A ^a   Tormans, G ^b   Gupta, A K ^c   Van Rossem, K ^d   Eggleston, A ^d   Dubois, D J ^d   De Doncker, P ^d   Haneke, E ^e  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b BR1 International   (Belgium)

^c UNIVERSITY OF TORONTO   (Canada)

^d JANSSEN RESEARCH FOUNDATION   (Belgium)

^e HELIOS KLINIKUM WUPPERTAL   (Germany)

Author keywords

Itraconazole; Onychomycosis; Pharmacoeconomics

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROX; ITRACONAZOLE; TERBINAFINE;

ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG EFFICACY; FOLLOW UP; GERMANY; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; META ANALYSIS; NAIL; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PHARMACOECONOMICS; PRIORITY JOURNAL; SIDE EFFECT; TOPICAL DRUG ADMINISTRATION;

EID: 0029825346     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246254     Document Type: Article

References (36)

1. Gupta AK. Saudcr DN. Shear NH: Antifungal agents: An overview. Part I. J Am Acad Dermatol 1994;30:677-698.
2. Gupta AK. Saudcr DN. Shear NH: Antifungal agents: An overview. Part II. J Am Acad Dermatol 1994;30:911-933.
3. Arikian SR. Einarson TR. Kobelt-Nguyen G. et al: A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. Br J Dermatol 1994; 130:35-44.
4. DerSimonian R, Laird N: Meta-analysis in clinical trials. Controlled Clin Trials 1986:7: 177-188.
5. Vclanovich V: Meta-analysis for combining Bayesian probabilities. Med Hypotheses 1991: 35:192-195.
6. Willemsen M. De Doncker P. Willems J. et al: Post-treatment itraconazole levels in the nail. J Am Acad Dermatol 1992;26:731-735.
7. Haneke E. Delescluse J, Plinck EPB. et al: The use of itraconazole in onychomycosis: A review. Eur J Dermatol 1996:6:7-10.
8. Zaias N. Serrano L: The successful treatment of finger Trichophyton rubrum onychomycosis with oral tcrbinafine. Clin Exp Dermatol 1989: 14:120-123.
9. Good field MJD. Rowell NR. Forster RA. et al: Treatment of dermatophyte infection of the finger- and toe-nails with tcrbinafine (SF 86-327. Lamisil). an orally active fungicidal agent. Br J Dermatol 1989:121:753-757.
10. Goodtield MJD: Short-duration therapy with tcrbinafine for dermatophyte onychomycosis: A multicentre trial. Br J Dermatol 1992:126: 33-35.
11. Van Der Schroeff JG. Cirkcl PKS. Crijns MB. et al: A randomized treatment duration-finding study of terbinafine in onychomycosis. Br J Dermatol 1992:126:36-39.
12. Roberts DT. Richardson MD. Dwyer PK. et al: Terbinafine in chronic paronychia and candida onychomycosis. J Dermatol Treat 1992:3: 39-42.
13. Baudraz-Rossclct F. Rakosi T, Wili PB. et al: Treatment of onychomycosis with terbinafine. Br J Dermatol 1992:126:40-46.
14. Arenas R. Domingucz-Cherit J. Fernandez L: Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int J Dermatol 1995:34:138-143.
15. Degrcef H. Oris S, Borghijs AM, et al: Management of onychomycosis with oral itraconazole: The change from long-term treatment attitude towards shorther and fixed therapy approach (abstract). 18th World Congr Dermatol, New York City, June 12-18, 1992, p48A.
16. Havu V, Brandt H, Heillilae H. et al: A randomized. blind-blind trial comparing continuous itraconazole treatment with itraconazole puls; therapy in the treatment of toenail onychomycosis, submitted.
17. Nolling S. Brautigam M. Weidinger G: Tcrbinafine in onychomycosis with involvement by nondermatophytic fungi. Br J Dermatol 1994;130:16-21.
18. Gutter G: Antifungal pulse therapy in toenail onychomycosis: Austrian experience. 2nd Int Symp Onychomycosis. Florence, September 28-29. 1995.
19. Bonifaz A. Saul A: Pulsos de itraconazole cn onicomicosis. (Estudio preliminar). XVI Congr Mex Dermatol, Mazatlan. Sinaloa. October 18-22. 1994.
20. Nolting S. Seebachcr C: Ciclopiroxolamin: Wegweiser topischer Mykose-Thcrapic. Uni-versitiitsverlag Jena GmbH. Frankfurt am Main. 1993, pp 1-124.
21. Kim J, Aim K. Kim J, Efficacy and tolerability of itraconazole in patients with fingernail onychomycosis: A 6 week pilot study. Curr Thcr Res 1995;56:1066-1075.
22. Ilay RJ. Clayton YM: Treatment of chronic dermatophytosis and chronic oral candidiasis with itraconazole. Rev Infect Dis 1987:9: S114-S118.
23. Walsoe I, Stangerup M. Svejgaard E: Itraconazole in onychomycosis: Open and double-blind studies. Acta Derm Venereol (Stockh) 1990; 70:137-140.
24. Rongioletti F. Robert E. Tripodi S. et al: Treatment of onychomycosis with itraconazole. J Dermatol Treat 1991;2:145-146.
25. Korting HC, Schiifer-Korting M, Zienicke H, et al: Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole. Antimi-crob Agents Chemother 1993:37:2064-2068.
26. Piepponen T, Blomqvist K, Brandt H, et al: Efficacy and safety of itraconazole in the longterm treatment of onychomycosis. J Antimi-crob Chemother 1992:29:195-205.
27. Goodfield MJD: Clinical results with tcr-binafine in onychomycosis. J Dermatol Treat 1990:1:55-57.
28. Goodfield MJD. Andrew L, Evans EGV: Short-term treatment of dermatophyte onychomycosis with terbinafinc. Br Med J 1992; 304:1151-1154.
29. Zaias N: Management of onychomycosis with oral terbinafinc. J Am Acad Dermatol 1990:23: 810-812.
30. Rakosi T: Terbinafine and onychomycosis. Dermatologica 1990:181:74.
31. Arenas R. Fernandez G. Dominguez L: Onychomycosis treated with itraconazole or gris-cofulvin alone with and without a topical antimycotic or keratolytic agent. Int J Dermatol 1991:30:586-589.
32. Hay RJ. Clayton YM. Moore MK, et al: An evaluation of itraconazole in the management of onychomycosis. Br J Dermatol 1988:119: 359-366.
33. Davis R. Balfour JA: Terbinafine: A pharma-coeconomic evaluation of its use in superficial fungal infections. Pharmacocconomics 1995: 8:253-269.
34. Cauwcnbcrgh G. Degreef H. Heykcnts J. et al: Phannacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988:18:263-268.
35. De Doncker P, Van Lint J. Dockx P. et al: Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis. Cutis 1995;56:180-183.
36. De Doncker P. Decroix J. Pierard GE, et al: Antifungal pulse therapy in onychomycosis: A pharmacokinetic/pharmacodynamic investigation of monthly cycles of I week pulse with itraconazole. Arch Dermatol 1996;132:34-41